Global pharma researchers focus on combination drug to ensure total hepatitis … – pharmabiz.com
[unable to retrieve full-text content]
Global pharma researchers focus on combination drug to ensure total hepatitis ... pharmabiz.com According to World Health Organization, India accounts for over 40 million (4 crore) patients with hepatitis B virus (HBV) infection. “The desired objective of antiviral therapy for hepatitis B&C is permanent removal of the virus from the body. ... |